Zenas BioPharma Eyes US IPO Amid Investor Optimism
Bristol-Myers Squibb-backed Zenas BioPharma files for US IPO as market hopes for rate cuts and reduced volatility rise.
- Latest
- Trending
Bristol-Myers Squibb-backed Zenas BioPharma files for US IPO as market hopes for rate cuts and reduced volatility rise.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.